FDA Is Expected to Lift Restriction on Peptides, Heeding RFK Jr.'s Wishes The New York Times Action Alert: Protect Access to Compounded Peptides Federal regulators are making decisions right now that could determine the future of peptide based therapies in the U.S. Compounded peptides such as BPC 157 and epitalon FDA to Convene Expert Panel on Expanding Access to Peptides Amid Safety, Regulatory Debate AJMC RFK Jr pushes for FDA approval of BPC 157 peptide Eric Topol, MD posted on the topic LinkedIn